China SXT Pharmaceuticals Inc banner

China SXT Pharmaceuticals Inc
NASDAQ:SXTC

Watchlist Manager
China SXT Pharmaceuticals Inc Logo
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Watchlist
Price: 2.42 USD 7.56% Market Closed
Market Cap: $2.3m

China SXT Pharmaceuticals Inc
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

China SXT Pharmaceuticals Inc
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Inventory
$751.4k
CAGR 3-Years
6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Inventory
¥653.5m
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Inventory
¥6.2B
CAGR 3-Years
38%
CAGR 5-Years
24%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Inventory
¥2.7B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Inventory
¥5.8B
CAGR 3-Years
-13%
CAGR 5-Years
-14%
CAGR 10-Years
0%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Inventory
¥162.2m
CAGR 3-Years
25%
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

China SXT Pharmaceuticals Inc
Glance View

Market Cap
2.3m USD
Industry
Pharmaceuticals

China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 96 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.

SXTC Intrinsic Value
6.75 USD
Undervaluation 64%
Intrinsic Value
Price

See Also

What is China SXT Pharmaceuticals Inc's Inventory?
Inventory
751.4k USD

Based on the financial report for Sep 30, 2025, China SXT Pharmaceuticals Inc's Inventory amounts to 751.4k USD.

What is China SXT Pharmaceuticals Inc's Inventory growth rate?
Inventory CAGR 5Y
-3%

Over the last year, the Inventory growth was -13%. The average annual Inventory growth rates for China SXT Pharmaceuticals Inc have been 6% over the past three years , -3% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett